Delfini Lisa
SEC insider (Form 3/4/5 filer). CIK 0001873253. Chief Financial Officer at Trevi Therapeutics, Inc. (TRVI). 5 reported Form 4/5 transactions since Sep 2024; latest on May 31, 2025. Located in NEW HAVEN, CT.
Companies Delfini Lisa has filed insider reports for
- Trevi Therapeutics, Inc. (TRVI): Officer, Chief Financial Officer
Delfini Lisa
CIK: 0001873253
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Trevi Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 31, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectPerformance Stock Option (right to buy)
72K shares- - Mar 10, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectPerformance Stock Option (right to buy)
38.4K shares- - Feb 18, 2025TRVI
Trevi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
225.5K shares- - Jan 8, 2025TRVI
Trevi Therapeutics, Inc.
ExerciseDirect5K shares at avg. $0.51$3K - Jan 7, 2025TRVI
Trevi Therapeutics, Inc.
ExerciseDirect1K shares at avg. $0.51$511
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 31, 2025 | TRVI Trevi Therapeutics, Inc. | Award Performance Stock Option (right to buy) | 72,000 | - | - | Direct |
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | Award Performance Stock Option (right to buy) | 38,400 | - | - | Direct |
| Feb 18, 2025 | TRVI Trevi Therapeutics, Inc. | Award Stock Option (right to buy) | 225,500 | - | - | Direct |
| Jan 8, 2025 | TRVI Trevi Therapeutics, Inc. | Exercise | 5,000 | $0.51 | $2,555 | Direct |
| Jan 7, 2025 | TRVI Trevi Therapeutics, Inc. | Exercise | 1,000 | $0.51 | $511 | Direct |
1-5 of 5 transactions